IE45753B1 - Composition and method for combating virus infections - Google Patents

Composition and method for combating virus infections

Info

Publication number
IE45753B1
IE45753B1 IE1311/77A IE131177A IE45753B1 IE 45753 B1 IE45753 B1 IE 45753B1 IE 1311/77 A IE1311/77 A IE 1311/77A IE 131177 A IE131177 A IE 131177A IE 45753 B1 IE45753 B1 IE 45753B1
Authority
IE
Ireland
Prior art keywords
treatment
phosphonoformic acid
viruses
infections caused
preparation
Prior art date
Application number
IE1311/77A
Other languages
English (en)
Other versions
IE45753L (en
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE45753(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of IE45753L publication Critical patent/IE45753L/xx
Publication of IE45753B1 publication Critical patent/IE45753B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IE1311/77A 1976-07-01 1977-06-27 Composition and method for combating virus infections IE45753B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Publications (2)

Publication Number Publication Date
IE45753L IE45753L (en) 1978-01-01
IE45753B1 true IE45753B1 (en) 1982-11-17

Family

ID=20328354

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1311/77A IE45753B1 (en) 1976-07-01 1977-06-27 Composition and method for combating virus infections

Country Status (22)

Country Link
US (4) US4215113A (cg-RX-API-DMAC10.html)
JP (1) JPS536428A (cg-RX-API-DMAC10.html)
AT (1) AT369014B (cg-RX-API-DMAC10.html)
AU (1) AU510809B2 (cg-RX-API-DMAC10.html)
BE (1) BE856355A (cg-RX-API-DMAC10.html)
BG (1) BG60834B2 (cg-RX-API-DMAC10.html)
CA (1) CA1077848A (cg-RX-API-DMAC10.html)
CH (1) CH641471A5 (cg-RX-API-DMAC10.html)
DE (1) DE2728685C2 (cg-RX-API-DMAC10.html)
DK (1) DK288877A (cg-RX-API-DMAC10.html)
FI (1) FI772030A7 (cg-RX-API-DMAC10.html)
FR (1) FR2356424A1 (cg-RX-API-DMAC10.html)
GB (1) GB1585615A (cg-RX-API-DMAC10.html)
HK (1) HK28984A (cg-RX-API-DMAC10.html)
IE (1) IE45753B1 (cg-RX-API-DMAC10.html)
LU (2) LU77666A1 (cg-RX-API-DMAC10.html)
MX (1) MX9203635A (cg-RX-API-DMAC10.html)
MY (1) MY8500125A (cg-RX-API-DMAC10.html)
NL (2) NL180068C (cg-RX-API-DMAC10.html)
NO (1) NO772299L (cg-RX-API-DMAC10.html)
SE (1) SE7607496L (cg-RX-API-DMAC10.html)
SG (1) SG80383G (cg-RX-API-DMAC10.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
DK564378A (da) * 1977-12-22 1979-06-23 Astra Laekemedel Ab Fremgangsmaade til fremstilling af amidderivater til bekaempelse af virusinfektioner
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
WO1983002723A1 (en) * 1982-02-12 1983-08-18 Smith, Kendall, O. Anti-viral compositions
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
WO1987002246A1 (en) * 1985-10-21 1987-04-23 William Sergio Method for reducing the risk or probability of infection from the aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
WO1996039148A1 (en) * 1995-06-06 1996-12-12 University Of Southern California Methods and compositions for inhibiting cytomegalovirus replication
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
RU2116790C1 (ru) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Наружное противоинфекционное средство "рефарм"
RU2124881C1 (ru) * 1997-11-26 1999-01-20 Матковская Татьяна Александровна Наружное лечебно-косметическое средство
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
EP1603542A1 (en) * 2003-03-14 2005-12-14 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
US20090214676A1 (en) * 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
WO2009114153A1 (en) * 2008-03-12 2009-09-17 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (en) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Transmucosal dosage forms of foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Also Published As

Publication number Publication date
AU2650577A (en) 1979-01-04
AU510809B2 (en) 1980-07-17
GB1585615A (en) 1981-03-11
SE7607496L (sv) 1978-01-02
MY8500125A (en) 1985-12-31
DE2728685A1 (de) 1978-01-12
NL7707235A (nl) 1978-01-03
NO772299L (no) 1978-04-25
US4215113A (en) 1980-07-29
FI772030A7 (cg-RX-API-DMAC10.html) 1978-01-02
NL930053I2 (nl) 1994-01-03
NL930053I1 (nl) 1993-09-01
LU88310I2 (fr) 1994-05-04
US4339445A (en) 1982-07-13
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
SG80383G (en) 1984-08-03
US4665062A (en) 1987-05-12
CH641471A5 (de) 1984-02-29
BE856355A (fr) 1978-01-02
NL180068B (nl) 1986-08-01
CA1077848A (en) 1980-05-20
AT369014B (de) 1982-11-25
DE2728685C2 (de) 1982-09-16
NL180068C (nl) 1987-01-02
DK288877A (da) 1978-01-02
LU77666A1 (cg-RX-API-DMAC10.html) 1977-10-07
FR2356424A1 (fr) 1978-01-27
FR2356424B1 (cg-RX-API-DMAC10.html) 1980-04-18
US4771041A (en) 1988-09-13
JPS562046B2 (cg-RX-API-DMAC10.html) 1981-01-17
MX9203635A (es) 1992-09-01
JPS536428A (en) 1978-01-20
BG60834B2 (bg) 1996-04-30
ATA465477A (de) 1982-04-15

Similar Documents

Publication Publication Date Title
US4215113A (en) Method for combating virus infections
Bean Antiviral therapy: current concepts and practices
SU799664A3 (ru) Способ получени 9-(2-оксиэтоксиметил)гуАНиНА или ЕгО СОлЕй
NO154751B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksykarbonylfosfonsyreestere.
EP4248997A1 (en) Therapeutic agent or prophylactic agent for covid-19
US5039667A (en) Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
Neyts et al. The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1, 3-dihydroxy-2-propoxy) methyl] purine is a potent and selective inhibitor of herpesvirus replication
WO1990014831A2 (en) 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
EP0302760B1 (en) Antiviral therapy for hepatitis b using 2',3'-dideoxynucleosides
KR100196339B1 (ko) Hiv-1 감염의 치료를 위한 펜시클로버 및 팜시클로버 및 관련된 구아닌 유도체
CA1261265A (en) METHOD OF MEDICAL TREATMENT OF HUMAN VIRAL DISEASES UTILIZING 1-.beta.-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3- CARBOXAMIDE
HK1004527B (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
US6492352B1 (en) Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5077279A (en) 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
EP0365139A2 (en) Bile acids for the treatment of viral infections
Miyai et al. Synthesis and anti-deoxyribonucleic acid virus activity of certain 9-. beta.-D-arabinofuranosyl-2-substituted adenine derivatives
NO784332L (no) Amidderivater, farmasoeytiske preparater og fremgangsmaate til bekjempelse av virusinfeksjoner
US5674869A (en) Pharmaceutical treatment
Mandel et al. The effect of 4-amino-5-imidazolecarboxamide on the incorporation of purines into liver nucleic acids of the mouse
EP0082667A1 (en) Pharmaceutical compositions
JPH02247191A (ja) 抗レトロウイルス剤としてのプリンおよびピリミジン非環状ヌクレオシドの環状モノホスフエート類
JPH0544925B2 (cg-RX-API-DMAC10.html)
JPH03209321A (ja) 抗レトロウイルス薬
JPH06227982A (ja) 抗ウイルス剤
JPS63310826A (ja) 抗ウィルス剤

Legal Events

Date Code Title Description
MK9A Patent expired